Allogene Therapeutics, Inc. | ||||
NMS : ALLO || Location: United States | ||||
$4.46+0.25 (+5.94%) |
1.9 M | 4.14 - 4.63 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 27.749 M |
Feb. 29, 2024 | 25.008 M |
Feb. 15, 2024 | 23.448 M |
Jan. 31, 2024 | 23.086 M |
Jan. 12, 2024 | 30.206 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.46 | -0.43 | 6.13% |
09/30/2023 | -0.53 | -0.37 | 30.18% |
06/30/2023 | -0.60 | -0.53 | 11.77% |
03/31/2023 | -0.63 | -0.68 | -8.02% |
12/31/2022 | -0.71 | -0.66 | 7.43% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 169.092M | Shares Float | 110.182M |
Short Float | 27.749M | Market Cap | 754.15M |
Institution ownership | 73.78% | Insider ownership | 22.440% |
Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
Trailing EPS | -2.09 | Forward EPS | -1.55 |